Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (17)

« Back to Publications

Fibroblast specialisation across microanatomy in a single-cell atlas of healthy human Achilles tendon

Cohen CJ. et al, (2025)

Belantamab Mafodotin Triggers Immune Invigoration in Multiple Myeloma Via Inflammatory and Immunogenic Cell Death

Watson ECR. et al, (2025)

Cellular and molecular landscapes of human tendons across the lifespan revealed by spatial and single-cell transcriptomics

Kurjan A. et al, (2025)

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Yedier-Bayram O. et al, (2025), Exp Mol Med, 57, 1294 - 1307

Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma

Kala EY. et al, (2025)

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer

Yedier-Bayram O. et al, (2024)

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.

Ozyerli-Goknar E. et al, (2023), Cell Commun Signal, 21

Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival

Ozyerli-Goknar E. et al, (2022)

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.

Yedier-Bayram O. et al, (2022), Cell Death Dis, 13

Overcoming chemoresistance in triple negative breast cancer by bromodomain inhibition

Yedier-Bayram O. et al, (2022), EUROPEAN JOURNAL OF CANCER, 174, S69 - S69

micropillar-based microfluidic viscometer for Newtonian and non-Newtonian fluids.

Mustafa A. et al, (2020), Anal Chim Acta, 1135, 107 - 115

Nesprin-1 impact on tumorigenic cell phenotypes.

Sur-Erdem I. et al, (2020), Mol Biol Rep, 47, 921 - 934

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma.

Senbabaoglu F. et al, (2020), Front Neurosci, 14

Differential effects of adenylyl cyclase-protein kinase A cascade on shear-induced changes of sickle cell deformability.

Ugurel E. et al, (2019), Clin Hemorheol Microcirc, 73, 531 - 543

Nitrite may serve as a combination partner and a biomarker for the anti-cancer activity of RRx-001.

Cirrik S. et al, (2019), Biorheology, 56, 221 - 235

Load More